These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6119463)

  • 21. Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis.
    Senagore AJ; MacKeigan JM; Scheider M; Ebrom JS
    Dis Colon Rectum; 1992 Oct; 35(10):923-7. PubMed ID: 1395977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial.
    Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ
    Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
    Andreoli A; Spinella S; Levenstein S; Prantera C
    Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesalamine for ulcerative colitis.
    Med Lett Drugs Ther; 1988 May; 30(766):53-4. PubMed ID: 3283508
    [No Abstract]   [Full Text] [Related]  

  • 25. [5-aminosalicylic acid enema (Pentasa) versus hydrocortisone acetate foam (Proctocort) for the treatment of outbreaks of proctitis and cryptogenetic proctosigmoiditis. A comparative randomized multicenter trial].
    Ngô Y; Rambaud JC
    Gastroenterol Clin Biol; 1992; 16(6-7):558-63. PubMed ID: 1526418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of mesalamine in rectal suspension diluted with distilled water.
    Henderson LM; Johnson CE; Berardi RR
    Am J Hosp Pharm; 1994 Dec; 51(23):2955-7. PubMed ID: 7879807
    [No Abstract]   [Full Text] [Related]  

  • 27. Sulfasalazine and new analogues.
    Friedman G
    Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined therapy with 5-aminosalicylic tablets and enemas for maintaining remission in ulcerative colitis.
    d'Albasio G; Trallori G; Gavazzi O; Bardazzi G; Vannozzi G; Frittelli G; Cini E; Falai T; Varini C; Morettini A
    Ital J Gastroenterol; 1991 Jan; 23(1):12-4. PubMed ID: 1747494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminosalicylates: old and new.
    Hanauer SB
    Mt Sinai J Med; 1990 Oct; 57(5):283-7. PubMed ID: 1982892
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute pancreatitis induced by mesalazine.
    Tran K; Froguel E; Jian R; Lemann M; Modigliani R
    J Clin Gastroenterol; 1991 Dec; 13(6):715-6. PubMed ID: 1761847
    [No Abstract]   [Full Text] [Related]  

  • 31. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.
    d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A
    Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulphasalazine in inflammatory bowel disease: recent advances.
    Cooper BT
    N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428
    [No Abstract]   [Full Text] [Related]  

  • 33. Low Pentasa dosage versus hydrocortisone in the topical treatment of active ulcerative colitis: a randomized, double-blind study.
    Bianchi Porro G; Ardizzone S; Petrillo M; Fasoli A; Molteni P; Imbesi V
    Am J Gastroenterol; 1995 May; 90(5):736-9. PubMed ID: 7733079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
    Kam L; Cohen H; Dooley C; Rubin P; Orchard J
    Am J Gastroenterol; 1996 Jul; 91(7):1338-42. PubMed ID: 8677990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrograde distribution of a new 5-aminosalicylic acid enema in patients with ulcerative colitis.
    Almer S; Ekberg S; Ström M
    Gastroenterol Clin Biol; 1992; 16(6-7):564-8. PubMed ID: 1526419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Aminosalicylic acid for the treatment of inflammatory bowel disease.
    Dew MJ; Evans BK; Rhodes J
    Gastroenterology; 1984 Aug; 87(2):480-1. PubMed ID: 6735091
    [No Abstract]   [Full Text] [Related]  

  • 37. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
    Segars LW; Gales BJ
    Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New treatments of hemorrhagic rectocolitis].
    Rambaud JC
    Ann Gastroenterol Hepatol (Paris); 1988; 24(4):173-7. PubMed ID: 2901821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H
    Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
    Sandborn WJ; Hanauer SB; Buch A
    Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.